Î¥ÏÎ¿ÏÏÎ³Î¹ÎºÎ® Î±ÏÏÏÎ±ÏÎ·

More documents

Recommendations

Info

19130 ΕΦΗΜΕΡΙΣ ΤΗΣ ΚΥΒΕΡΝΗΣΕΩΣ (ΤΕΥΧΟΣ ΔΕΥΤΕΡΟ) J - ATC / . DDD MON J02AC02 ITRA 2587401 03 STERGINOX CAPS 100MG/CAP BTX15 (BLIST 3X5) 0.2 G 7.500 1.2600 9.45 8.73 J02AC02 ITRA 2587401 04 STERGINOX CAPS 100MG/CAP BTX28 (BLIST 4X7) 0.2 G 14.000 1.1079 15.51 15.51 J02AC02 ITRA 2477202 04 MESMOR CAPS 100MG/CAP BTX28(BLIST 4X7) RAFARM A.E.B.E. 0.2 G 14.000 1.1079 15.51 15.51 J02AC02 ITRA 2605401 02 ITRACON CAPS 100MG/CAP BTx18 (3 BLIST x 6) VIANEX A.E. 0.2 G 9.000 1.1844 10.66 10.47 J02AC02 ITRA 2605401 01 ITRACON CAPS 100MG/CAP BTx6 (1 BLIST x 6) VIANEX A.E. 0.2 G 3.000 1.6633 4.99 3.49 J02AC02 ITRA 2624401 03 FLUNOL CAPS 100MG/CAP () BTx15 (BLIST 3x5) PHARMA Q A.E. 0.2 G 7.500 1.2600 9.45 8.73 ( ) J02AC02 ITRACONAZOLE J02AC02 ITRA 2540501 01 ASSOSEPT-S ORAL.SOL 10MG/ML BTx1 FLx150 ML S.J.A. PHARM 0.2 G 7.500 4.0120 30.09 30.09 J02AC02 ITRA 2604801 01 BROVICTON ORAL.SOL 10MG/ML BTxBOTTLEx150ML BROS ... 0.2 G 7.500 4.0120 30.09 30.09 J02AC02 ITRA 2656601 01 DERATIL ORAL.SOL 10MG/ML BOTTLEx150 ML HELP 0.2 G 7.500 4.0120 30.09 30.09 J02AC02 ITRA 2591901 01 ISOFLON ORAL.SOL 10MG/ML FL x 150 ML 0.2 G 7.500 4.0120 30.09 30.09 J02AC02 ITRA 2548601 01 ITRABEST ORAL.SOL 10MG/ML FLx150 ML 0.2 G 7.500 4.0120 30.09 30.09 J02AC02 ITRA 2511201 01 ITRAZOL ORAL.SOL 10MG/ML BOTTLEx150 ML VERISFIELD (UK) L 0.2 G 7.500 4.0120 30.09 30.09 J02AC02 ITRA 2477201 01 MESMOR ORAL.SOL 50MG/5ML BOTTLEX150ML RAFARM A.E.B.E. 0.2 G 7.500 4.0120 30.09 30.09 J02AC02 ITRA 2703901 01 MYCODROX ORAL.SOL 10MG/ML BTx1 (BOTTLEx150 D.A.S.T. BIOTECH 0.2 G 7.500 4.0120 30.09 30.09 J02AC02 ITRA 2674901 01 NEO-CANDIMYK ORAL.SOL 10MG/ML VIALx150 ML VIOFAR 0.2 G 7.500 4.0120 30.09 30.09 J02AC02 ITRA 2549601 01 SOPRAZON ORAL.SOL 50MG/5ML BTX1(BOTTLEX150M 0.2 G 7.500 4.0120 30.09 30.09 J02AC02 ITRA 1965902 01 SPORANOX ORAL.SOL 10MG/ML BOTTLE x 150 ML JANSSEN-CILAG 0.2 G 7.500 5.0160 37.62 30.09 ( ) J02AC02 ITRACONAZOLE J02AC02 ITRA 2619901 02 MICRONAZOL C/S.SOL.IN 10MG/ML BTx(1 AMPx25 ML+1 HOSPITAL LINE A. 0.2 G 1.250 44.3200 55.40 55.40 J02AC02 ITRA 1965903 01 SPORANOX I.V. C/S.SOL.IN 10MG/ML BTx[(BTx1AMPx25M JANSSEN-CILAG 0.2 G 1.250 55.4080 69.26 55.40 J02AC G3 - / ( ) J02AC03 VORICONAZOLE J02AC03 VOR 2511001 03 VFEND F.C.TAB 50MG/TAB BTX14 PFIZER L.T.D. ENG 0.4 G 1.750 91.9429 160.90 135.32 J02AC03 VOR 2511002 03 VFEND F.C.TAB 200MG/TAB 14 PFIZER L.T.D. ENG 0.4 G 7.000 75.4871 528.41 528.41
ΕΦΗΜΕΡΙΣ ΤΗΣ ΚΥΒΕΡΝΗΣΕΩΣ (ΤΕΥΧΟΣ ΔΕΥΤΕΡΟ) 19131 J - ATC / . DDD MON ( ) J02AC03 VORICONAZOLE J02AC03 VOR 2511004 01 VFEND PD.ORA.SUS 40MG/ML 45G PFIZER L.T.D. ENG 0.4 G 7.500 74.9480 562.11 562.11 ( ) J02AC03 VORICONAZOLE J02AC03 VOR 2511003 01 VFEND PD.SOL.INF 200MG/VIAL BTX1VIAL( PFIZER L.T.D. ENG 0.4 G 0.500 274.4200 137.21 137.21 J02AC G4 - / ( ) J02AC04 POSACONAZOLE J02AC04 POS 2709301 01 NOXAFIL ORAL.SUSP 40 MG/ML . . X 105 ml MERCK SHARP&D 0.8 G 5.250 123.0248 645.88 645.88 J02AX - J02AX G1 - / ( ) J02AX04 CASPOFUNGIN ACETATE J02AX04 CAS 2509001 01 CANCIDAS PD.C.SO.IN 50MG/VIAL BTX1VIALX50MG MERCK SHARP&D 0.05 G 1.000 424.6200 424.62 379.96 J02AX04 CAS 2509002 01 CANCIDAS PD.C.SO.IN 70MG/VIAL BTX1VIALX70MG MERCK SHARP&D 0.05 G 1.400 379.9571 531.94 531.94 J02AX G2 - / ( ) J02AX05 MICAFUNGIN SODIUM J02AX05 MIC 2837201 01 MYCAMINE PD.SOL.INF 50MG/10ML VIAL BTx1 VIALx10 ML ASTELLAS PHARM 0.1 G 0.500 481.4000 240.70 219.24 J02AX05 MIC 2837202 01 MYCAMINE PD.SOL.INF 100MG/10ML VIAL BTx1 VIALx10 ML ASTELLAS PHARM 0.1 G 1.000 395.5500 395.55 395.55 J02AX G3 - / ( ) J02AX06 ANIDULAFUNGIN J02AX06 ANI 2812302 01 ECALTA PD.C.SO.IN 100MG/VIAL x1 VIAL PFIZER L.T.D. ENG 0.1 G 1.000 373.4300 373.43 373.43
Page 1 and 2:
18959 ΕΦΗΜΕΡΙΣ ΤΗΣ ΚΥ
Page 3 and 4:
ΕΦΗΜΕΡΙΣ ΤΗΣ ΚΥΒΕΡ
Page 5 and 6:
Page 7 and 8:
Page 9 and 10:
Page 11 and 12:
Page 13 and 14:
Page 15 and 16:
Page 17 and 18:
Page 19 and 20:
Page 21 and 22:
Page 23 and 24:
Page 25 and 26:
Page 27 and 28:
Page 29 and 30:
Page 31 and 32:
Page 33 and 34:
Page 35 and 36:
Page 37 and 38:
Page 39 and 40:
Page 41 and 42:
Page 43 and 44:
Page 45 and 46:
Page 47 and 48:
Page 49 and 50:
Page 51 and 52:
Page 53 and 54:
Page 55 and 56:
Page 57 and 58:
Page 59 and 60:
Page 61 and 62:
Page 63 and 64:
Page 65 and 66:
Page 67 and 68:
Page 69 and 70:
Page 71 and 72:
Page 73 and 74:
Page 75 and 76:
Page 77 and 78:
Page 79 and 80:
Page 81 and 82:
Page 83 and 84:
Page 85 and 86:
Page 87 and 88:
Page 89 and 90:
Page 91 and 92:
Page 93 and 94:
Page 95 and 96:
Page 97 and 98:
Page 99 and 100:
Page 101 and 102:
Page 103 and 104:
Page 105 and 106:
Page 107 and 108:
Page 109 and 110:
Page 111 and 112:
Page 113 and 114:
Page 115 and 116:
Page 117 and 118:
Page 119 and 120:
Page 121 and 122: ΕΦΗΜΕΡΙΣ ΤΗΣ ΚΥΒΕΡ
Page 171: ΕΦΗΜΕΡΙΣ ΤΗΣ ΚΥΒΕΡ
Page 223 and 224:
Page 225 and 226:
Page 227 and 228:
Page 229 and 230:
Page 231 and 232:
Page 233 and 234:
Page 235 and 236:
Page 237 and 238:
Page 239 and 240:
Page 241 and 242:
Page 243 and 244:
Page 245 and 246:
Page 247 and 248:
Page 249 and 250:
Page 251 and 252:
Page 253 and 254:
Page 255 and 256:
Page 257 and 258:
Page 259 and 260:
Page 261 and 262:
Page 263 and 264:
Page 265 and 266:
Page 267 and 268:
Page 269 and 270:
Page 271 and 272:
Page 273 and 274:
Page 275 and 276:
Page 277 and 278:
Page 279 and 280:
Page 281 and 282:
Page 283 and 284:
Page 285 and 286:
Page 287 and 288:
Page 289 and 290:
Page 291 and 292:
Page 293 and 294:
Page 295 and 296:
Page 297 and 298:
Page 299 and 300:
Page 301 and 302:
Page 303 and 304:
Page 305 and 306:
Page 307 and 308:
Page 309 and 310:
Page 311 and 312:
Page 313 and 314:
Page 315 and 316:
Page 317 and 318:
Page 319 and 320:
Page 321 and 322:
Page 323 and 324:
Page 325 and 326:
Page 327 and 328:
Page 329 and 330:
Page 331 and 332:
Page 333 and 334:
Page 335 and 336:
Page 337 and 338:
Page 339 and 340:
Page 341 and 342:
Page 343 and 344:
show all

Î¥ÏÎ¿Ï ÏÎ³Î¹ÎºÎ® Î±ÏÏÏÎ±ÏÎ·

Create successful ePaper yourself

Delete template?

Save as template?

Î¥ÏÎ¿ÏÏÎ³Î¹ÎºÎ® Î±ÏÏÏÎ±ÏÎ·